Chargement en cours...
Baseline history of patients using selexipag for pulmonary arterial hypertension
INTRODUCTION: Since its introduction to the market in 2016, selexipag has been an alternative oral therapy among both treatment-naïve patients and those with mono or dual therapy failure; however, limited information is available regarding the presentation and management of patients with pulmonary a...
Enregistré dans:
| Publié dans: | Ther Adv Respir Dis |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6466463/ https://ncbi.nlm.nih.gov/pubmed/30983530 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753466619843774 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|